Beta-Amyloid (1-42) • HFIP
- Cat.Number : AS-64129-05
- Manufacturer Ref. :
-
Availability :
In stock
Alternative choices
Removal of any preexisting structures in lyophilized stocks of Aβ-peptide is the critical initial step for controlled aggregation studies. HFIP has been shown to break down β-sheet structure, disrupt hydrophobic forces in aggregated amyloid preparations, and promote α-helical secondary structure. HFIP treatment of lyophilized Aβ-peptide results in a dense, homogeneous preparation of unaggregated peptide and samples can be stored as peptide films.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
CAS registry number |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Application | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)
References
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
J Biol Chem . 2003 Mar 01 ; 278(13) 11612 | DOI : https://doi.org/10.1074/jbc.M210207200
- W.B. Stine
- et al